Discover

LH
Labcorp Holdings Inc.
260.97
40 x 261.02
80 x 272.85
bid
ask
+
2.05
0.79%
60 @ 05:53 PM
257.13 -3.84 (1.47%)
Ytd 4.02%
1y 2.59%
259.99
day range
267.12
241.81
52 week range
293.72
Open 262.29 Prev Close 258.92 Low 259.99 High 267.12 Mkt Cap 21.40B
Vol 519.61K Avg Vol 628.52K EPS 11.29 P/E 23.12 Forward P/E 13.26
Beta 0.88 Short Ratio 4.61 Inst. Own 100.42% Dividend 2.88 Div Yield 1.12
Ex Div Date 05-29 Earning 07-23 50-d Avg 262.27 200-d Avg 268.16 1yr Est 310.12
Earning
Date For Estimate Reported Surprise surprise %
2026-04-30 2026-03 4.09 4.25 0.16 3.91%
2026-02-17 2025-12 3.95 4.07 0.12 3.04%
2025-10-28 2025-09 4.13 4.18 0.05 1.21%
2025-07-24 2025-06 4.14 4.35 0.21 5.07%
2025-04-29 2025-03 3.73 3.84 0.11 2.95%
2025-02-06 2024-12 3.4 3.45 0.05 1.47%
Upgrade / Downgrade
Date Firm Action From To
2026-04-08 Evercore ISI Group Upgrade Outperform Outperform
2026-02-24 Piper Sandler Upgrade Neutral Neutral
2026-02-18 JP Morgan Upgrade Overweight Overweight
2026-02-18 Baird Upgrade Outperform Outperform
2026-02-06 JP Morgan Upgrade Overweight Overweight
2025-11-07 JP Morgan Upgrade Overweight Overweight
Profile
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Insider Holder
Date Name Relation Quantity Description
2026-02-10 ANDERSON KERRII B Director 9.85K Conversion of Exercise of derivative security
2025-03-26 BERBERIAN LANCE V Officer 18.65K Stock Award(Grant)
2026-03-25 CAVENEY BRIAN J Officer 36.49K Stock Award(Grant)
2025-03-26 EISENBERG GLENN A Officer 37.92K Stock Award(Grant)
2026-02-10 KONG GARHENG Director 13.74K Conversion of Exercise of derivative security
2026-02-10 NEUPERT PETER M Director 13.78K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 6.44M 1.68B 7.86%
2026-03-30 Vanguard Capital Management LLC 5.38M 1.40B 6.56%
2026-03-30 Victory Capital Management Inc. 4.63M 1.21B 5.64%
2026-03-30 State Street Corporation 3.86M 1.01B 4.71%
2026-03-30 Vanguard Portfolio Management LLC 3.68M 960.36M 4.49%
2026-03-30 Boston Partners 2.37M 618.07M 2.89%
Fund Ownership
Report Date Organization Position Value Percentage
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 2.62M 682.66M 3.19%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 2.11M 549.84M 2.57%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 1.78M 464.31M 2.17%
2026-03-30 ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund 1.52M 396.94M 1.86%
2026-03-30 Victory Portfolios-Victory Sycamore Established Value Fund 1.44M 374.42M 1.75%
2026-03-30 -Victory Pioneer Fund 1.16M 301.97M 1.41%
Dividend
Dividend Date
0.72 2026-05-29
0.72 2026-02-27
0.72 2025-11-26
0.72 2025-08-28
0.72 2025-05-29
0.72 2025-02-27
Split
Split Date
2 : 1 2002-05-13
2 : 1 2001-06-12
0.1 : 1 2000-05-04